AGM date
Previous AGM date
Proposal number
Resolution details
Company ticker
Submitted by
Resolution ask
Strengthen board oversight of issue
ESG theme
  • Governance
ESG sub-theme
  • Shareholder rights
Type of vote
Director vote
Filer type
Company sector
Health Care
Company HQ country
United States
Whereas clause
The following directors have been nominated for election at the 2023 Annual meeting:

1) Daniel P. O'Day - 92.89% FOR
(i) Chair of Board of Directors

2) Kevin E. Lofton - 92.61%
(i) Chair of Compensation and Talent Committee
(ii) Member of Audit Committee
(iii) Member of Nominating & Corporate Governance Committee

3) Jacqueline K. Barton - 98.65% FOR
(i) Member of Compensation and Talent Committee
(ii) Member of Science Committee

4) Jeffrey A. Bluestone - 99.6% FOR
(i) Member of Science Committee

5) Sandra J. Morning -98.12% FOR
(i) Chair of Science Committee
(ii) Member of Nominating and Corporate Governance Committee

6) Kelly A. Kramer - 96.7% FOR
(i) Chair of Audit Committee
(ii) Member of Compensaiton and Talent Committee

7) Harish Manwani - 95.99% FOR
(i) Member of Compensation and Talent Committee
(ii) Member of Nominating and Corporate Governance Committee

8) Javier J. Rodriguez - 99.36%
(i) Member of Audit Committee

9) Anthony Welters - 95.53%
(i) Chair of Nominating and Corporate Governance Committee
(ii) Member of Compensation and Talent Committee

Supporting statement
Last year, shareholders voted: (i) 56.8% in favour of a proposal titled 'Reduce ownership threshold for shareholders to call special meeting' and (ii) 50.22% in favour of a proposal titled 'Publish third-party review of alignment of company's lobbying activities'. PRI research finds that as of 01 March 2023 there is no evidence that the company has been responsive to shareholder views on this matter.

The 2022 proxy season had one of the highest records for majority-supported environmental, social, and governance (ESG) shareholder proposals in recent years, according to PWC. But as the 2023 proxy season commences, companies are acting on – and implementing – less than two out of every five of those shareholder proposals, according to their proponents. In approximately a quarter of cases, the investor proponent believes the proposal will not be addressed at all.

Access the research here:

DISCLAIMER: By including a shareholder resolution or management proposal in this database, neither the PRI nor the sponsor of the resolution or proposal is seeking authority to act as proxy for any shareholder; shareholders should vote their proxies in accordance with their own policies and requirements.

Any voting recommendations set forth in the descriptions of the resolutions and management proposals included in this database are made by the sponsors of those resolutions and proposals, and do not represent the views of the PRI.

Information on the shareholder resolutions, management proposals and votes in this database have been obtained from sources that are believed to be reliable, but the PRI does not represent that it is accurate, complete, or up-to-date, including information relating to resolutions and management proposals, other signatories’ vote pre-declarations (including voting rationales), or the current status of a resolution or proposal. You should consult companies’ proxy statements for complete information on all matters to be voted on at a meeting.